Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_assertion type Assertion NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_head.
- NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_assertion description "[Amplification of ERBB-2 was detected in 14 out of 63 (22%) cases of breast carcinoma, in 1 out of 23 patients with ovarian cancers, in 1 out of 19 cases of colon carcinoma and in 1 out of 27 patients with thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_provenance.
- NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_assertion evidence source_evidence_literature NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_provenance.
- NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_assertion SIO_000772 1349430 NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_provenance.
- NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_assertion wasDerivedFrom befree-20140225 NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_provenance.
- NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_assertion wasGeneratedBy ECO_0000203 NP430598.RA4ohg7EaFmF-WvT1yk2pS0LdpIWvbk9wEOC5YteKJ0Rc130_provenance.